Emerging Longevity Ventures

Emerging Longevity Ventures is a venture capital firm that focuses on biotechnology investments. It has made one investment, deploying $5 million in total...

Emerging Longevity Ventures

Emerging Longevity Ventures is a venture capital firm that focuses on biotechnology investments. It has made one investment, deploying $5 million in total capital.

Website

emerginglongevityventures.com

General information

Firm type

Venture Capital

Year founded

2017

Location

Region

North America

Country

United States

City

Mountain View

Corporate office

Mountain View, CA, United States

Additional offices

San Diego, CA, United States

Sector focus

AI/MLDigital HealthAgriTech & FoodTech

What investment stages does Emerging Longevity Ventures typically target?

The firm focuses on early-stage companies, based on its sector tags and typical venture capital posture. No specific stage ranges (e.g., seed, Series A) have been publicly confirmed.

What is Emerging Longevity Ventures' known posture on co-investments alongside external GPs?

Co-investment practices are not publicly documented. Without confirmed portfolio companies or partnerships, the firm's co-investment posture remains unknown.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Source record modified: Jun 3, 2026. Public records carry source-specific dates where available. No population-wide measured refresh cadence or universal verification deadline is established here. Page modified, source captured, fact observed, entity verified and aggregate measured describe different events. Check the date attached to the relevant claim; a missing verification date means unknown. Stored source history does not establish a customer-facing historical-analysis interface. To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.